THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kelly Stratton to Male

Back to Details
This is a "connection" page, showing publications Kelly Stratton has written about Male.
Kelly Stratton
Connection Strength
0.511
Male
  1. Effects of primary care physician density, urologist presence, and insurance status on stage of diagnosis for urologic malignancies. Cancer Epidemiol. 2018 02; 52:10-14.
    View in: PubMed
    Score: 0.050
  2. Cystectomy for cT4 prostate cancer: the most radical treatment. BJU Int. 2017 11; 120(5B):E6-E7.
    View in: PubMed
    Score: 0.050
  3. Castration-Resistant Prostate Cancer: An Algorithmic Approach. Urol Clin North Am. 2017 Nov; 44(4):647-655.
    View in: PubMed
    Score: 0.050
  4. A Contemporary Review of HPV and Penile Cancer. Oncology (Williston Park). 2016 Mar; 30(3):245-9.
    View in: PubMed
    Score: 0.044
  5. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes. Urol Oncol. 2016 May; 34(5):238.e1-7.
    View in: PubMed
    Score: 0.044
  6. Editorial Comment for Bolton et al. J Endourol. 2015 Jul; 29(7):850.
    View in: PubMed
    Score: 0.042
  7. Locally advanced prostate cancer: the role of surgical management. BJU Int. 2009 Aug; 104(4):449-54.
    View in: PubMed
    Score: 0.028
  8. A pilot randomized clinical trial of a smartphone-based application to support at-home PSA screening and culturally tailored prostate cancer education for African American men: A study protocol. Contemp Clin Trials. 2024 Dec; 147:107737.
    View in: PubMed
    Score: 0.020
  9. PF-06952229, a selective TGF-?-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors. ESMO Open. 2024 Sep; 9(9):103653.
    View in: PubMed
    Score: 0.020
  10. Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians. Prostate. 2020 10; 80(14):1159-1176.
    View in: PubMed
    Score: 0.015
  11. Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98.
    View in: PubMed
    Score: 0.012
  12. Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database. Urology. 2017 May; 103:99-105.
    View in: PubMed
    Score: 0.012
  13. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Cancer. 2017 Jul 01; 123(13):2452-2458.
    View in: PubMed
    Score: 0.012
  14. Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clin Genitourin Cancer. 2016 12; 14(6):511-517.
    View in: PubMed
    Score: 0.011
  15. A Germline Variant on Chromosome 4q31.1 Associates with Susceptibility to Developing Colon Cancer Metastasis. PLoS One. 2016; 11(1):e0146435.
    View in: PubMed
    Score: 0.011
  16. Intramuscular Heating Characteristics of Multihour Low-Intensity Therapeutic Ultrasound. J Athl Train. 2015 Nov; 50(11):1158-64.
    View in: PubMed
    Score: 0.011
  17. An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality. Br J Cancer. 2015 Jun 30; 113(1):166-72.
    View in: PubMed
    Score: 0.011
  18. Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol. 2015 Sep; 194(3):626-34.
    View in: PubMed
    Score: 0.010
  19. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma. Urol Oncol. 2015 Jan; 33(1):21.e11-21.e17.
    View in: PubMed
    Score: 0.010
  20. Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device. Urol Oncol. 2014 Jan; 32(1):45.e11-5.
    View in: PubMed
    Score: 0.009
  21. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int. 2012 Dec; 110(11 Pt B):E641-6.
    View in: PubMed
    Score: 0.009
  22. Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma. Urology. 2011 Jul; 78(1):99-104.
    View in: PubMed
    Score: 0.008
  23. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011 Jun; 59(6):923-8.
    View in: PubMed
    Score: 0.008
  24. Open renal biopsy: comorbidities and complications in a contemporary series. BJU Int. 2010 Jul; 106(1):102-6.
    View in: PubMed
    Score: 0.007
  25. Prognostic factors in T3b renal cell carcinoma. World J Urol. 2009 Feb; 27(1):75-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES